4 623

Cited 25 times in

Clinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology.

DC Field Value Language
dc.contributor.author최승호-
dc.contributor.author형우진-
dc.contributor.author노성훈-
dc.contributor.author박경호-
dc.contributor.author윤미진-
dc.contributor.author정재호-
dc.date.accessioned2014-12-20T17:16:59Z-
dc.date.available2014-12-20T17:16:59Z-
dc.date.issued2011-
dc.identifier.issn0022-4790-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/94304-
dc.description.abstractBACKGROUND AND OBJECTIVES: The purpose of this study was to investigate the role of the standardized uptake values (SUV), a semi-quantitative assessment of tumor FDG uptake, as a prognosticator for advanced signet ring cell carcinoma (SRC). METHODS: We reviewed the files of 41 patients who underwent curative gastrectomy for advanced SRC and who had an FDG-PET at initial presentation between September 2003 and December 2007. RESULTS: The median follow-up period was 30.9 months (range: 4.0-70.3). We found a correlation between the SUVmax and TNM stage. When the patients were divided into two groups (low vs. high SUVmax) based on a median SUVmax of 3.80, the high-SUVmax group showed more aggressive tumor behavior than did the low SUVmax group. In addition, the high SUVmax group showed more postoperative recurrence (P = 0.028), shorter relapse-free survival (P = 0.004), and lower 30-month cancer-specific survival rates (40.0% vs. 69.3%, P = 0.008). However, in multivariate analysis, SUVmax failed to be an independent predictor of overall survival. CONCLUSIONS: Although SUVmax of initial PET scan was not an independent predictor of patient outcomes after curative surgery, higher SUVmax is associated with more advanced stage and indicates more aggressive tumor biology in advanced SRC.-
dc.description.statementOfResponsibilityopen-
dc.format.extent566~570-
dc.relation.isPartOfJOURNAL OF SURGICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHCarcinoma,SignetRingCell/diagnostic imaging*-
dc.subject.MESHCarcinoma,SignetRingCell/pathology-
dc.subject.MESHCarcinoma,SignetRingCell/surgery-
dc.subject.MESHFemale-
dc.subject.MESHFluorodeoxyglucose F18*-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHGastrectomy-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNeoplasm Staging-
dc.subject.MESHPositron-Emission Tomography*-
dc.subject.MESHRadiopharmaceuticals*-
dc.subject.MESHStomach Neoplasms/diagnostic imaging*-
dc.subject.MESHStomach Neoplasms/pathology-
dc.subject.MESHStomach Neoplasms/surgery-
dc.subject.MESHSurvival Rate-
dc.subject.MESHTreatment Outcome-
dc.titleClinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학)-
dc.contributor.googleauthorKyung Ho Pak-
dc.contributor.googleauthorMijin Yun-
dc.contributor.googleauthorJae-Ho Cheong-
dc.contributor.googleauthorWoo Jin Hyung-
dc.contributor.googleauthorSeung Ho Choi-
dc.contributor.googleauthorSung Hoon Noh-
dc.identifier.doi10.1002/jso.21997-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA04102-
dc.contributor.localIdA04382-
dc.contributor.localIdA01281-
dc.contributor.localIdA01426-
dc.contributor.localIdA02550-
dc.contributor.localIdA03717-
dc.relation.journalcodeJ01762-
dc.identifier.eissn1096-9098-
dc.identifier.pmid21671462-
dc.identifier.urlhttp://onlinelibrary.wiley.com/doi/10.1002/jso.21997/abstract-
dc.subject.keywordstandard uptake values-
dc.subject.keywordsignet ring cell carcinoma-
dc.subject.keywordFDG–PET-
dc.contributor.alternativeNameChoi, Seung Ho-
dc.contributor.alternativeNameHyung, Woo Jin-
dc.contributor.alternativeNameNoh, Sung Hoon-
dc.contributor.alternativeNamePak, Kyung Ho-
dc.contributor.alternativeNameYun, Mi Jin-
dc.contributor.alternativeNameCheong, Jae Ho-
dc.contributor.affiliatedAuthorChoi, Seung Ho-
dc.contributor.affiliatedAuthorHyung, Woo Jin-
dc.contributor.affiliatedAuthorNoh, Sung Hoon-
dc.contributor.affiliatedAuthorPak, Kyung Ho-
dc.contributor.affiliatedAuthorYun, Mi Jin-
dc.contributor.affiliatedAuthorCheong, Jae Ho-
dc.rights.accessRightsnot free-
dc.citation.volume104-
dc.citation.number6-
dc.citation.startPage566-
dc.citation.endPage570-
dc.identifier.bibliographicCitationJOURNAL OF SURGICAL ONCOLOGY, Vol.104(6) : 566-570, 2011-
dc.identifier.rimsid27530-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Nuclear Medicine (핵의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.